Introduction:Basic information about CAS 13739-02-1|Diacerein, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
Diacerein, a interleukin-1 beta inhibitor, is a slow-acting medicine of the class anthraquinone used to treat joint diseases.Target: IL-1 betaDiacerein, a interleukin-1 beta inhibitor, is a slow-acting medicine of the class anthraquinone used to treat joint diseases. Diacerein works by blocking the actions of interleukin-1 beta, a protein involved in the inflammation and destruction of cartilage that play a role in the development of symptoms of degenerative joint diseases such as osteoarthritis. Due to its specific mode of action, which does not involve the inhibition of prostaglandin synthesis, diacerein has been shown to have anti-osteoarthritis and cartilage stimulating properties in vitro and animal models, together with analgesic and anti-inflammatory properties. Due to its excellent gastro-intestinal tolerance, a combination therapy with an analgesic or a NSAID may be recommended during the first 2-4 weeks of treatment. From Wikipedia.
Related Catalog
Signaling Pathways >>Immunology/Inflammation >>Interleukin RelatedResearch Areas >>Inflammation/ImmunologyNatural Products >>Quinones
Details of toxic effects not reported other than lethal dose value
REFERENCE :
DRFUD4 Drugs of the Future. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1975/76- Volume(issue)/page/year: 4,445,1979
Safety Information
Symbol
GHS07
Signal Word
Warning
Hazard Statements
H315-H319-H335
Precautionary Statements
P305 + P351 + P338
Hazard Codes
Xi
Risk Phrases
36/37/38
Safety Phrases
26-36
RIDADR
NONH for all modes of transport
WGK Germany
3
RTECS
CB8781000
HS Code
2918990090
Customs
HS Code
2918990090
Summary
2918990090. other carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides and peroxyacids; their halogenated, sulphonated, nitrated or nitrosated derivatives. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%
Articles9
More Articles
[Diacerein].
Ann. Ital. Med. Int. 1(2) , 172-4, (1986)
[Efficacy of diacerein on the symptoms and radiographic progression of osteoarthritis].
Presse Med. 31(39 Pt 2) , 4S13-5, (2002)
SYMPTOMATIC EFFECTS OF DIACEREIN: Data obtained from several clinical trials have demonstrated that relief of joint pain obtained with the interleukin-1 inhibitor diacerein is comparable with that obs...
Diacerein as a disease-modulating agent in osteoarthritis.
Curr. Rheumatol. Rep. 3(6) , 479-83, (2001)
This paper reviews the most recent clinical and experimental studies on diacerein, both of which are under investigation. Diacerein could be a disease-modulating agent in osteoarthritis because struct...